CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.

• Phase: Phase 2

Details

• Lead Sponsor: RSPR Pharma AB

Criteria

Inclusion Criteria:

• Infra-renal abdominal aortic aneurysm

Exclusion Criteria:

• Previous infra-renal aortic surgery

• Known diabetes